Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Vitamin D Repletion in Primary Hyperparathyroidism

Phase 4

Completed

Conditions: Primary Hyperparathyroidism
Vitamin D Deficiency

Interventions: Drug: 10,000 IU Vitamin D3
Other: Placebo
Dietary Supplement: Vitamin D

First Posted Date: 2011-03-02

Last Posted Date: 2019-04-16

Lead Sponsor: Columbia University

Target Recruit Count: 9

Registration Number: NCT01306656

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Reducing Sleep Disparities in Minority Children

Not Applicable

Completed

Conditions: Sleep

Interventions: Behavioral: Sleep Counselor Intervention
Other: Sleep Education Control

First Posted Date: 2011-02-23

Last Posted Date: 2015-02-04

Lead Sponsor: Columbia University

Target Recruit Count: 90

Registration Number: NCT01301989

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus

Phase 2

Completed

Conditions: Barrett's Esophagus

Interventions: Drug: Placebo
Drug: YF476

First Posted Date: 2011-02-18

Last Posted Date: 2021-11-23

Lead Sponsor: Columbia University

Target Recruit Count: 27

Registration Number: NCT01298999

Locations: 🇺🇸
New York Presbyterian Hospital - Columbia, New York, New York, United States
🇬🇧
National Institute for Health Research, Cambridge, United Kingdom

Decreasing Medication Errors by Caregivers Using a Health Literacy Intervention

Not Applicable

Terminated

Conditions: Medication Administration
Medication Errors

Interventions: Other: Medication administration educational module

First Posted Date: 2011-02-11

Last Posted Date: 2015-04-24

Lead Sponsor: Columbia University

Target Recruit Count: 132

Registration Number: NCT01294501

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy Pain

Phase 3

Terminated

Conditions: Idiopathic Peripheral Neuropathy

Interventions: Drug: Placebo
Drug: Milnacipran

First Posted Date: 2011-02-03

Last Posted Date: 2020-09-03

Lead Sponsor: Columbia University

Target Recruit Count: 6

Registration Number: NCT01288937

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Cytokine Production and Immunity to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster Vaccine

Completed

Conditions: Immunity; Defect Due to Antibody or Cell Mediated Immune Defect

First Posted Date: 2011-02-02

Last Posted Date: 2017-07-19

Lead Sponsor: Columbia University

Target Recruit Count: 26

Registration Number: NCT01288014

Locations: 🇺🇸
Vanderbilt Clinic, Columbia University Medical Center, New York, New York, United States

HIV/STI Prevention for Drug-Involved Couples

Not Applicable

Completed

Conditions: Sexually Transmitted Infections

Interventions: Behavioral: Couple Wellness Promotion
Behavioral: Couple HIV/STI prevention intervention
Behavioral: Individual HIV/STI prevention
Behavioral: Couple-based HIV/STI prevention

First Posted Date: 2011-01-28

Last Posted Date: 2019-01-14

Lead Sponsor: Columbia University

Target Recruit Count: 564

Registration Number: NCT01285349

Locations: 🇺🇸
Social Intervention Group/Columbia University School of Social Work, New York, New York, United States

Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study

Not Applicable

Completed

Conditions: Non-Alcoholic Fatty Liver Disease

Interventions: Drug: Fish Oil Supplementation
Drug: Placebo Supplementation

First Posted Date: 2011-01-28

Last Posted Date: 2022-05-05

Lead Sponsor: Columbia University

Target Recruit Count: 8

Registration Number: NCT01285362

Locations: 🇺🇸
Irving Clinical Research Center (GCRC) at Columbia University Medical Center, New York, New York, United States

Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis

Completed

Conditions: Genetic Diseases

Interventions: Genetic: Microarray analysis

First Posted Date: 2011-01-19

Last Posted Date: 2012-08-22

Lead Sponsor: Columbia University

Target Recruit Count: 4450

Registration Number: NCT01279733

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Lenalidomide in HTLV-1 Adult T-Cell Leukemia

Phase 2

Completed

Conditions: Adult T Cell Leukemia/Lymphoma

Interventions: Drug: Lenalidomide

First Posted Date: 2011-01-11

Last Posted Date: 2016-05-23

Lead Sponsor: Columbia University

Target Recruit Count: 4

Registration Number: NCT01274533

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy